Palatin Technologies
PTN
#10465
Rank
โ‚ฌ2.11 M
Marketcap
0,08147 โ‚ฌ
Share price
-44.65%
Change (1 day)
-94.75%
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : โ‚ฌ8.75 Million

According to Palatin Technologies's latest financial reports the company's total liabilities are โ‚ฌ8.75 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2025)

20052010201520202025โ‚ฌ20Mโ‚ฌ40Mโ‚ฌ60Mโ‚ฌ80Mcompaniesmarketcap.com

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚ฌ10.11 M-44.6%
2023-06-30โ‚ฌ18.24 M-3.44%
2022-06-30โ‚ฌ18.9 M27%
2021-06-30โ‚ฌ14.88 M242.59%
2020-06-30โ‚ฌ4.34 M17.94%
2019-06-30โ‚ฌ3.68 M-64.23%
2018-06-30โ‚ฌ10.29 M-81.05%
2017-06-30โ‚ฌ54.33 M112.14%
2016-06-30โ‚ฌ25.61 M65.13%
2015-06-30โ‚ฌ15.5 M666.66%
2014-06-30โ‚ฌ2.02 M25.62%
2013-06-30โ‚ฌ1.61 M-42.57%
2012-06-30โ‚ฌ2.8 M36.37%
2011-06-30โ‚ฌ2.05 M-16.24%
2010-06-30โ‚ฌ2.45 M-64.88%
2009-06-30โ‚ฌ6.99 M-12.43%
2008-06-30โ‚ฌ7.98 M-55.75%
2007-06-30โ‚ฌ18.04 M5.08%
2006-06-30โ‚ฌ17.16 M-21%
2005-06-30โ‚ฌ21.73 M214.15%
2004-06-30โ‚ฌ6.91 M94.68%
2003-06-30โ‚ฌ3.55 M-3.96%
2002-06-30โ‚ฌ3.69 M35.01%
2001-06-30โ‚ฌ2.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
MediciNova
MNOV
โ‚ฌ2.16 M-75.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
โ‚ฌ2.26 M-74.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.99 B 11,288.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.73 B 8,292.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ95.15 M 986.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ100.05 B 1,142,313.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.22 B 2,514.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ56.38 B 643,677.93%๐Ÿ‡ฌ๐Ÿ‡ง UK